BEAT - BioTelemetry EPS beats by $0.08 beats on revenue July, 30 2020 04:25 PM Heartbeam Inc. BioTelemetry (NASDAQ:BEAT): Q2 Non-GAAP EPS of $0.35; GAAP EPS of $0.06 beats by $0.08.More news on: BioTelemetry, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...